Unknown

Dataset Information

Influence of diabetes on sacubitril/valsartan titration and clinical outcomes in patients hospitalized for heart failure.


ABSTRACT:

Aims

Diabetes mellitus is associated with worse outcomes and lower attainment of disease-modifying therapies in patients with heart failure with reduced ejection fraction (HFrEF). This post hoc analysis of TRANSITION compared the patterns of tolerability and uptitration of sacubitril/valsartan in patients with HFrEF stabilized after hospital admission due to acute decompensated HF depending on the presence or absence of diabetes as a co-morbidity.

Methods

TRANSITION, a randomized, open-label study compared sacubitril/valsartan initiation pre-discharge vs. post-discharge (up to14 days) in 991 patients hospitalized for acutely decompensated HFrEF. The impact of diabetes status on tolerability and safety was studied at 10-week and 26-week post-randomization.

Results

Amon

SUBMITTER: Witte KK 

PROVIDER: S-EPMC9871669 | biostudies-literature | 2023 Feb

REPOSITORIES: biostudies-literature